Population Pharmacokinetic/Pharmacodynamic Analyses of Avatrombopag in Patients With Chronic Liver Disease and Optimal Dose Adjustment Guide With Concomitantly Administered CYP3A and CYP2C9 Inhibitors

2018 ◽  
Vol 58 (12) ◽  
pp. 1629-1638 ◽  
Author(s):  
Maiko Nomoto ◽  
Jim Ferry ◽  
Ziad Hussein
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Dose Adjustment ◽  
Optimal Dose ◽  
Chronic Liver ◽  
Population Pharmacokinetic

Genetic predictors of spontaneous viral elimination or chronic liver disease in hepatitis C infection

2001 ◽  
Vol 120 (5) ◽  
pp. A7-A7
Author(s):  
S ROSS ◽  
S MASCHERETTI ◽  
H HINRICHSEN ◽  
P BUGGISCH ◽  
U FOELSCH ◽  
...  
Keyword(s):  
Liver Disease ◽  
Hepatitis C ◽  
Chronic Liver Disease ◽  
Chronic Liver ◽  
Hepatitis C Infection ◽  
Genetic Predictors

Functional effects of methylthioadenosine phosphorylase (MTAP) expression in chronic liver disease

2013 ◽  
Vol 51 (01) ◽  
Author(s):  
B Czech ◽  
D Valletta ◽  
K Dettmer ◽  
M Müller ◽  
A Bosserhoff ◽  
...  
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Chronic Liver ◽  
Methylthioadenosine Phosphorylase

PCR-based methods for the detection of fungal DNA in patients with chronic liver disease

2014 ◽  
Vol 52 (08) ◽  
Author(s):  
S Krohn ◽  
C Engelmann ◽  
S Böhm ◽  
K Zeller ◽  
T Berg
Keyword(s):  
Liver Disease ◽  
Chronic Liver Disease ◽  
Chronic Liver ◽  
Fungal Dna
Sign in / Sign up

Export Citation Format

Share Document